Slator Life Sciences and Language AI Report
The Slator Life Sciences and Language AI Report provides an in-depth analysis of the pharmaceutical...
#pharmaceutical
Array
(
[post_type] => post
[posts_per_page] => 12
[paged] => 1
[post_status] => publish
[tax_query] => Array
(
[relation] => AND
[0] => Array
(
[taxonomy] => post_tag
[field] => term_id
[terms] => 22182
[operator] => IN
)
)
)
Translation Services and the Race for a Coronavirus Vaccine
With hundreds of coronavirus clinical studies underway, what role does the language industry play in...
Deadline 2020: What LSPs Need to Know About the EU’s New Medical Device Regulation
Europe’s new medical device regulation requires that labeling, packaging, and other content be translated into...
Honyaku Center Posts Decline in Translation Revenues for H1 FY 2020
Honyaku Center reports decline in all sectors of core Translation Business, except for Patents. Banks...
Shares in Japan’s Largest LSP Plummet on Declining Q1 FY20 Revenues
Shares in Japanese language service provider Honyaku Center plummet on declining Q1 2020 sales. Its...
Slator 2019 Life Sciences Translation Report
Slator’s 2019 report on the clinical life sciences translation industry, analysis of the competitive landscape...
Why Linguistic Validation Requires Not Just Conceptual but Cultural Equivalence
Adelina Lear of contract research organization ICON plc spoke at SlatorCon London on the role...